Literature DB >> 22354766

Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up.

Hany Eldeeb1, Iman Awad, Osman Elhanafy.   

Abstract

To compare three fractionation schedules in post-mastectomy patients treated with radiotherapy as regard acute and early late effects as well as local recurrence rates. One hundred and seven breast cancer patients treated with modified radical mastectomy and adjuvant radiotherapy±adjuvant systemic treatments between November 2001 and July 2004 were enrolled in this study. Patients were categorized into three groups. Group A (41 patients) received conventional fractionation 50 Gy over 25 fractions. Group B (36 patients) received other fractionation regimen 45 Gy over 17 fractions. Group C (30 patients) received 40 Gy over 15 fractions. The median follow-up period was 23 months. There has been no statistical significant difference in local control (P=0.88), pain (P=0.98), telangectasis (P=0.23), fibrosis (P=0.13), arm oedema (P=0.96) or pigmentation (P=0.80) between the three groups. GII-III Erythema was significantly higher in the two hypofractionation arms compared to the control arm (P=0.001). Although acute skin reactions were higher in the hypofractionated arms, there was no significant difference in the local recurrence rates or late radiation effects. A national randomized multicentre study is recommended to explore this further.

Entities:  

Mesh:

Year:  2012        PMID: 22354766     DOI: 10.1007/s12032-012-0192-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  35 in total

1.  Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients.

Authors:  S Johansson; H Svensson; J Denekamp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  [Post-mastectomy radiotherapy with different fractionated dose schemes in early breast cancer].

Authors:  Jun-xin Wu; Zhou-guang Hui; Ye-xiong Li; Zi-hao Yu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2003-05

3.  Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effort?

Authors:  Mia Voordeckers; Jan Van de Steene; Vincent Vinh-Hung; Guy Storme
Journal:  Radiother Oncol       Date:  2003-09       Impact factor: 6.280

4.  Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology.

Authors:  J R Yarnold; P Price; G G Steel
Journal:  Clin Oncol (R Coll Radiol)       Date:  1995       Impact factor: 4.126

5.  The recording of morbidity related to radiotherapy.

Authors:  S Dische; M F Warburton; D Jones; E Lartigau
Journal:  Radiother Oncol       Date:  1989-10       Impact factor: 6.280

6.  The effects of single doses of X rays on the mechanical properties of pig skin in vivo.

Authors:  M R Baker; D Bader; J W Hopewell
Journal:  Br J Radiol       Date:  1989-09       Impact factor: 3.039

Review 7.  Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?

Authors:  Y Yamada; I Ackerman; E Franssen; R G MacKenzie; G Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-04-01       Impact factor: 7.038

8.  Postmastectomy CT-based electron beam radiotherapy: dosimetry, efficacy, and toxicity in 118 patients.

Authors:  Marnee M Spierer; Linda X Hong; Raquel T Wagman; Matthew S Katz; Rebecca L Spierer; Beryl McCormick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

9.  Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer.

Authors:  Timothy Whelan; Robert MacKenzie; Jim Julian; Mark Levine; Wendy Shelley; Laval Grimard; Barbara Lada; Himu Lukka; Francisco Perera; Anthony Fyles; Ethan Laukkanen; Sunil Gulavita; Veronique Benk; Barbara Szechtman
Journal:  J Natl Cancer Inst       Date:  2002-08-07       Impact factor: 13.506

10.  Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer.

Authors:  R M Clark; P B McCulloch; M N Levine; M Lipa; R H Wilkinson; L J Mahoney; V R Basrur; B D Nair; R S McDermot; C S Wong
Journal:  J Natl Cancer Inst       Date:  1992-05-06       Impact factor: 13.506

View more
  9 in total

1.  A Retrospective Analysis of Toxicity and Efficacy for 2 Hypofractionated Irradiation Schedules Versus a Conventional One for Post-Mastectomy Adjuvant Radiotherapy in Breast Cancer.

Authors:  Vassilis Kouloulias; Eftychia Mosa; Anna Zygogianni; Efrosini Kypraiou; John Georgakopoulos; Kalliopi Platoni; Christos Antypas; George Kyrgias; Maria Tolia; Christos Papadimitriou; Amanda Psyrri; George Patatoukas; Maria Dilvoi; Christina Armpilia; Kyriaki Theodorou; Maria-Aggeliki Kalogeridi; Ivelina Beli; John Kouvaris; Nikolaos Kelekis
Journal:  Breast Care (Basel)       Date:  2016-09-28       Impact factor: 2.860

2.  Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients.

Authors:  Yibo Xie; Beibei Guo; Rui Zhang
Journal:  Cost Eff Resour Alloc       Date:  2020-08-03

3.  Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.

Authors:  Sriram Venigalla; David M Guttmann; Varsha Jain; Sonam Sharma; Gary M Freedman; Jacob E Shabason
Journal:  Clin Breast Cancer       Date:  2018-02-21       Impact factor: 3.225

4.  Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.

Authors:  Chokaew Tovanabutra; Kanyarat Katanyoo; Pichet Uber; Kittisak Chomprasert; Sitthi Sukauichai
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01

5.  Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.

Authors:  Imjai Chitapanarux; Pitchayaponne Klunklin; Attapol Pinitpatcharalert; Patumrat Sripan; Ekkasit Tharavichitkul; Wannapha Nobnop; Wimrak Onchan; Somvilai Chakrabandhu; Bongkot Jia-Mahasap; Juntima Euathrongchit; Yutthaphan Wannasopha; Tanop Srisuwan
Journal:  Radiat Oncol       Date:  2019-10-14       Impact factor: 3.481

Review 6.  Hypofractionated Postmastectomy Radiation Therapy.

Authors:  Mutlay Sayan; Zeinab Abou Yehia; Nisha Ohri; Bruce G Haffty
Journal:  Adv Radiat Oncol       Date:  2020-11-21

7.  Feasibility, Tolerance, and Quality of Life for Hypofractionation Versus Conventional Fractionation for Post-mastectomy Radiotherapy in Indian Patients.

Authors:  Deepika Malik; Ashok Singh; Manoj M Birajdar; Virendra J Vyas
Journal:  Cureus       Date:  2022-03-25

8.  A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients.

Authors:  Kartick Rastogi; Sandeep Jain; Aseem Rai Bhatnagar; Sandeep Bhaskar; Shivani Gupta; Neeraj Sharma
Journal:  Asia Pac J Oncol Nurs       Date:  2018 Jan-Mar

Review 9.  The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.

Authors:  Gustavo Nader Marta; Charlotte Coles; Orit Kaidar-Person; Icro Meattini; Tarek Hijal; Yvonne Zissiadis; Jean-Philippe Pignol; Duvern Ramiah; Alice Y Ho; Skye Hung-Chun Cheng; Gemma Sancho; Birgitte Vrou Offersen; Philip Poortmans
Journal:  Crit Rev Oncol Hematol       Date:  2020-08-26       Impact factor: 6.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.